What question did this study set out to answer?

February 27, 2026Open Access

The effects of selenium supplementation on cardiovascular risk factors in patients with metabolic diseases ‒ A systematic review and meta-analysis of randomized controlled trials

Key Points

To evaluate the impact of selenium supplementation on cardiovascular risk factors in individuals with metabolic diseases.
Conducted a systematic review of randomized controlled trials
Included studies focusing on selenium supplementation in patients with metabolic diseases
Analyzed effects on insulin resistance, triglycerides, inflammation, and oxidative stress
Selenium supplementation improved insulin resistance in patients with metabolic diseases
Reduced triglyceride levels were observed with selenium supplementation
No significant effect was found on other aspects of glucose and lipid metabolism

Abstract

in conclusion, dietary selenium may improve insulin resistance, triglycerides, inflammation, and oxidative stress in individuals with metabolic diseases, but does not affect other aspects of glucose and lipid metabolism.

The effects of selenium supplementation on cardiovascular risk factors in patients with metabolic diseases ‒ A systematic review and meta-analysis of randomized controlled trials

Key Points

Abstract

Cite This Study